• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV-1 中和抗体的广谱性取决于其表位中关键位点的保守性。

The breadth of HIV-1 neutralizing antibodies depends on the conservation of key sites in their epitopes.

机构信息

U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, United States of America.

Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States of America.

出版信息

PLoS Comput Biol. 2019 Jun 6;15(6):e1007056. doi: 10.1371/journal.pcbi.1007056. eCollection 2019 Jun.

DOI:10.1371/journal.pcbi.1007056
PMID:31170145
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6581281/
Abstract

Developing HIV-1 vaccines that trigger broadly neutralizing antibodies (bnAbs) is a priority as bnAbs are considered key to elicitation of a protective immune response. To investigate whether the breadth of a neutralizing antibody (nAb) depended on the conservation of its epitope among circulating viruses, we examined Antibody:Envelope (Ab:Env) interactions and worldwide Env diversity. We found that sites corresponding to bnAb epitopes were as variable as other accessible, non-hypervariable Env sites (p = 0.50, Mann-Whitney U-test) with no significant relationship between epitope conservation and neutralization breadth (Spearman's ρ = -0.44, adjusted p = 0.079). However, when accounting for key sites in the Ab:Env interaction, we showed that the broadest bnAbs targeted more conserved epitopes (Spearman's ρ = -0.70, adjusted p = 5.0e-5). Neutralization breadth did not stem from the overall conservation of Ab epitopes but depended instead on the conservation of key sites of the Ab:Env interaction, revealing a mechanistic basis for neutralization breadth that could be exploited for vaccine design.

摘要

开发能够引发广泛中和抗体 (bnAbs) 的 HIV-1 疫苗是当务之急,因为 bnAbs 被认为是引发保护性免疫反应的关键。为了研究中和抗体 (nAb) 的广谱性是否取决于其表位在循环病毒中的保守性,我们研究了抗体:包膜 (Ab:Env) 相互作用和全球Env 多样性。我们发现,与其他可及的、非超变 Env 位点相比,对应 bnAb 表位的位点具有相同的变异性(p = 0.50,Mann-Whitney U 检验),表位保守性与中和广度之间没有显著关系(Spearman's ρ = -0.44,调整后 p = 0.079)。然而,当考虑到 Ab:Env 相互作用中的关键位点时,我们表明最广泛的 bnAbs 针对更保守的表位(Spearman's ρ = -0.70,调整后 p = 5.0e-5)。中和广度并非源于 Ab 表位的整体保守性,而是取决于 Ab:Env 相互作用的关键位点的保守性,这揭示了中和广度的机制基础,可以被用于疫苗设计。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7af/6581281/041fa0f4042b/pcbi.1007056.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7af/6581281/5abff1f5e10f/pcbi.1007056.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7af/6581281/945eab1fa17c/pcbi.1007056.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7af/6581281/28c11c88bcdd/pcbi.1007056.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7af/6581281/041fa0f4042b/pcbi.1007056.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7af/6581281/5abff1f5e10f/pcbi.1007056.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7af/6581281/945eab1fa17c/pcbi.1007056.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7af/6581281/28c11c88bcdd/pcbi.1007056.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d7af/6581281/041fa0f4042b/pcbi.1007056.g004.jpg

相似文献

1
The breadth of HIV-1 neutralizing antibodies depends on the conservation of key sites in their epitopes.HIV-1 中和抗体的广谱性取决于其表位中关键位点的保守性。
PLoS Comput Biol. 2019 Jun 6;15(6):e1007056. doi: 10.1371/journal.pcbi.1007056. eCollection 2019 Jun.
2
Positive Selection at Key Residues in the HIV Envelope Distinguishes Broad and Strain-Specific Plasma Neutralizing Antibodies.HIV 包膜关键残基的正选择可区分广谱和株特异性血浆中和抗体。
J Virol. 2019 Mar 5;93(6). doi: 10.1128/JVI.01685-18. Print 2019 Mar 15.
3
A Bispecific Antibody That Simultaneously Recognizes the V2- and V3-Glycan Epitopes of the HIV-1 Envelope Glycoprotein Is Broader and More Potent than Its Parental Antibodies.一种同时识别 HIV-1 包膜糖蛋白 V2-和 V3-聚糖表位的双特异性抗体比其亲本抗体更广泛和更有效。
mBio. 2020 Jan 14;11(1):e03080-19. doi: 10.1128/mBio.03080-19.
4
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design.HIV-1 中和抗体特征及其在表位靶向疫苗设计中的应用。
Cell Host Microbe. 2019 Jan 9;25(1):59-72.e8. doi: 10.1016/j.chom.2018.12.001.
5
HIV-1 Cross-Reactive Primary Virus Neutralizing Antibody Response Elicited by Immunization in Nonhuman Primates.非人灵长类动物免疫接种引发的HIV-1交叉反应性原发性病毒中和抗体反应
J Virol. 2017 Oct 13;91(21). doi: 10.1128/JVI.00910-17. Print 2017 Nov 1.
6
Neutralizing Activity of Broadly Neutralizing Anti-HIV-1 Antibodies against Clade B Clinical Isolates Produced in Peripheral Blood Mononuclear Cells.广泛中和性抗HIV-1抗体对在外周血单核细胞中产生的B亚型临床分离株的中和活性
J Virol. 2018 Feb 12;92(5). doi: 10.1128/JVI.01883-17. Print 2018 Mar 1.
7
Functional Stability of HIV-1 Envelope Trimer Affects Accessibility to Broadly Neutralizing Antibodies at Its Apex.HIV-1包膜三聚体的功能稳定性影响其顶端对广泛中和抗体的可及性。
J Virol. 2017 Nov 30;91(24). doi: 10.1128/JVI.01216-17. Print 2017 Dec 15.
8
Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop.从一名感染HIV-1 C亚型的精英中和者体内获得的构象表位特异性广泛中和性血浆抗体通过V1环区的突变介导自体病毒逃逸。
J Virol. 2016 Jan 13;90(7):3446-57. doi: 10.1128/JVI.03090-15.
9
An Antigenic Atlas of HIV-1 Escape from Broadly Neutralizing Antibodies Distinguishes Functional and Structural Epitopes.HIV-1 逃避广泛中和抗体的抗原图谱区分功能和结构表位。
Immunity. 2019 Feb 19;50(2):520-532.e3. doi: 10.1016/j.immuni.2018.12.017. Epub 2019 Jan 29.
10
Increased breadth of HIV-1 neutralization achieved by diverse antibody clones each with limited neutralization breadth.多种抗体克隆均可提高 HIV-1 中和广度,而每种克隆的中和广度有限。
PLoS One. 2018 Dec 19;13(12):e0209437. doi: 10.1371/journal.pone.0209437. eCollection 2018.

引用本文的文献

1
Distinct modes of evolution drive HIV escape from two broadly neutralizing antibodies.不同的进化模式促使HIV逃避两种广泛中和抗体。
bioRxiv. 2025 Aug 30:2025.08.29.673185. doi: 10.1101/2025.08.29.673185.
2
Contemporary HIV-1 consensus Env with AI-assisted redesigned hypervariable loops promote antibody binding.当代 HIV-1 共识Env 与人工智能辅助重新设计的超变环促进抗体结合。
Nat Commun. 2024 May 9;15(1):3924. doi: 10.1038/s41467-024-48139-x.
3
Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features.

本文引用的文献

1
HIV-1 Subtype C-Infected Children with Exceptional Neutralization Breadth Exhibit Polyclonal Responses Targeting Known Epitopes.HIV-1 亚型 C 感染儿童具有异常广泛的中和广度,表现出针对已知表位的多克隆反应。
J Virol. 2018 Aug 16;92(17). doi: 10.1128/JVI.00878-18. Print 2018 Sep 1.
2
HIV-1 Vaccines Based on Antibody Identification, B Cell Ontogeny, and Epitope Structure.基于抗体鉴定、B 细胞发生和表位结构的 HIV-1 疫苗。
Immunity. 2018 May 15;48(5):855-871. doi: 10.1016/j.immuni.2018.04.029.
3
Glycoengineering HIV-1 Env creates 'supercharged' and 'hybrid' glycans to increase neutralizing antibody potency, breadth and saturation.
广泛中和抗体 VRC01 的预防效果取决于 HIV-1 包膜序列特征。
Proc Natl Acad Sci U S A. 2024 Jan 23;121(4):e2308942121. doi: 10.1073/pnas.2308942121. Epub 2024 Jan 19.
4
Antibody targeting of conserved sites of vulnerability on the SARS-CoV-2 spike receptor-binding domain.抗体靶向 SARS-CoV-2 刺突受体结合域上的保守弱点。
Structure. 2024 Feb 1;32(2):131-147.e7. doi: 10.1016/j.str.2023.11.015. Epub 2023 Dec 28.
5
Enhancement of CD4 Binding, Host Cell Entry, and Sensitivity to CD4bs Antibody Inhibition Conferred by a Natural but Rare Polymorphism in the HIV-1 Envelope.一种自然发生但罕见的 HIV-1 包膜中的多态性增强了 CD4 结合、宿主细胞进入和对 CD4bs 抗体抑制的敏感性。
J Virol. 2022 Jul 27;96(14):e0185121. doi: 10.1128/jvi.01851-21. Epub 2022 Jul 5.
6
Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4.第二代 SIV 特异性抗体针对涉及与 CD4 结合的区域,广泛覆盖中和抗性 SIV 株。
PLoS Pathog. 2022 Jun 16;18(6):e1010574. doi: 10.1371/journal.ppat.1010574. eCollection 2022 Jun.
7
HIV-1 infections with multiple founders associate with the development of neutralization breadth.HIV-1 感染的多种起源与中和广度的发展有关。
PLoS Pathog. 2022 Mar 18;18(3):e1010369. doi: 10.1371/journal.ppat.1010369. eCollection 2022 Mar.
8
SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise.以HIV为对照描绘的新型冠状病毒2:相似伪装下的相反病毒策略
Microorganisms. 2021 Jun 27;9(7):1389. doi: 10.3390/microorganisms9071389.
9
Limited Evidence for a Relationship between HIV-1 Glycan Shield Features in Early Infection and the Development of Neutralization Breadth.早期感染中 HIV-1 聚糖屏蔽特征与中和广度发展之间关系的证据有限。
J Virol. 2021 Aug 10;95(17):e0079721. doi: 10.1128/JVI.00797-21.
10
Geospatial HIV-1 subtype C gp120 sequence diversity and its predicted impact on broadly neutralizing antibody sensitivity.地理空间 HIV-1 亚型 C gp120 序列多样性及其对广泛中和抗体敏感性的预测影响。
PLoS One. 2021 May 24;16(5):e0251969. doi: 10.1371/journal.pone.0251969. eCollection 2021.
糖基工程化 HIV-1 Env 产生“超级充电”和“杂交”聚糖,以提高中和抗体的效力、广度和饱和度。
PLoS Pathog. 2018 May 2;14(5):e1007024. doi: 10.1371/journal.ppat.1007024. eCollection 2018 May.
4
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies.开发一种能引发广泛中和抗体的抗HIV疫苗。
AIDS Res Ther. 2017 Sep 12;14(1):50. doi: 10.1186/s12981-017-0178-3.
5
Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation.HIV-1聚糖屏蔽对抗体诱导影响的定量分析。
Cell Rep. 2017 Apr 25;19(4):719-732. doi: 10.1016/j.celrep.2017.04.013.
6
Broad and potent cross clade neutralizing antibodies with multiple specificities in the plasma of HIV-1 subtype C infected individuals.广谱且强效的跨属中和抗体,在 HIV-1 亚型 C 感染个体的血浆中具有多种特异性。
Sci Rep. 2017 Apr 24;7:46557. doi: 10.1038/srep46557.
7
How HIV-1 entry mechanism and broadly neutralizing antibodies guide structure-based vaccine design.HIV-1的进入机制及广谱中和抗体如何指导基于结构的疫苗设计。
Curr Opin HIV AIDS. 2017 May;12(3):229-240. doi: 10.1097/COH.0000000000000360.
8
Developing an HIV vaccine.开发一种艾滋病病毒疫苗。
Science. 2017 Mar 17;355(6330):1129-1130. doi: 10.1126/science.aan0662. Epub 2017 Mar 16.
9
Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting.通过下一代中和指纹图谱绘制多克隆HIV-1抗体反应
PLoS Pathog. 2017 Jan 4;13(1):e1006148. doi: 10.1371/journal.ppat.1006148. eCollection 2017 Jan.
10
Determinants of HIV-1 broadly neutralizing antibody induction.HIV-1 广谱中和抗体诱导的决定因素。
Nat Med. 2016 Nov;22(11):1260-1267. doi: 10.1038/nm.4187. Epub 2016 Sep 26.